Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

TcY-NH2

TcY-NH2 ((trans-Cinnamoyl) -YPGKF-NH2) is a potent selective PAR4 antagonist peptide. tcY-NH2 inhibits thrombin- and AY-NH2-induced platelet aggregation and endostatin release, and can be used in the research of inflammation, immunology[1][2][6].

Product Specifications

CAS Number

[327177-34-4]

Product Name Alternative

(trans-Cinnamoyl) -YPGKF-NH2

UNSPSC

12352209

Target

Protease Activated Receptor (PAR)

Type

Peptides

Related Pathways

GPCR/G Protein

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Metabolic Disease; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/tcy-nh2.html

Purity

99.93

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

OC(C=C1)=CC=C1C[C@H](NC(/C=C/C2=CC=CC=C2)=O)C(N3[C@@H](CCC3)C(NCC(N[C@@H](CCCCN)C(N[C@H](C(N)=O)CC4=CC=CC=C4)=O)=O)=O)=O

Molecular Formula

C40H49N7O7

Molecular Weight

739.86

References & Citations

[1]Morley D Hollenberg, et al. Proteinase-activated receptor-4: evaluation of tethered ligand-derived peptides as probes for receptor function and as inflammatory agonists in vivo. Br J Pharmacol. 2004 Oct;143 (4) :443-54.|[2]L Ma, et al. Thrombin-induced platelet endostatin release is blocked by a proteinase activated receptor-4 (PAR4) antagonist. Br J Pharmacol. 2001 Oct;134 (4) :701-4.|[3]Hongbo Fang, et al. Blocking protease-activated receptor 4 alleviates liver injury induced by brain death. Biochem Biophys Res Commun. 2022 Mar 5;595:47-53. |[4]Matthias Bock, et al. Platelets differentially modulate CD4 + Treg activation via GPIIa/IIIb-, fibrinogen-, and PAR4-dependent pathways. Immunol Res. 2022 Apr;70 (2) :185-196. |[5]Jennifer L Strande, et al. Inhibiting protease-activated receptor 4 limits myocardial ischemia/reperfusion injury in rat hearts by unmasking adenosine signaling. J Pharmacol Exp Ther. 2008 Mar;324 (3) :1045-54. |[6]Lindisley F Gomides, et al. Blockade of proteinase-activated receptor 4 inhibits neutrophil recruitment in experimental inflammation in mice. Inflamm Res. 2014 Nov;63 (11) :935-41.

Shipping Conditions

Blue Ice

Storage Conditions

-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

Scientific Category

Peptides

Clinical Information

No Development Reported

Isoform

PAR4

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

GTF2A1 Antibody / TFIIA
V9649SAF-100UG 100 µg

GTF2A1 Antibody / TFIIA

Ask
View Details
2- (4-Methylpiperazinyl) -1-Phenylethylamine 99+% (HPLC)
229527-01 100 mg

2- (4-Methylpiperazinyl) -1-Phenylethylamine 99+% (HPLC)

Ask
View Details
2- (4-Methylpiperazinyl) -1-Phenylethylamine 99+% (HPLC)
229527-02 250 mg

2- (4-Methylpiperazinyl) -1-Phenylethylamine 99+% (HPLC)

Ask
View Details
2- (4-Methylpiperazinyl) -1-Phenylethylamine 99+% (HPLC)
229527-03 1 g

2- (4-Methylpiperazinyl) -1-Phenylethylamine 99+% (HPLC)

Ask
View Details
Lentiviral human CCDC6 shRNA (UAS) - Lentiviral human CCDC6 shRNA (UAS) (100)
GTR15086394 1 Vial

Lentiviral human CCDC6 shRNA (UAS) - Lentiviral human CCDC6 shRNA (UAS) (100)

Ask
View Details
Lentiviral mouse E130308A19Rik shRNA (UAS) - Lentiviral mouse E130308A19Rik shRNA (UAS, iRFP) (25)
GTR15180422 1 Vial

Lentiviral mouse E130308A19Rik shRNA (UAS) - Lentiviral mouse E130308A19Rik shRNA (UAS, iRFP) (25)

Ask
View Details